Ford is suspending production of its F-150 trucks. The FDA is warning of a nationwide shortage of EpiPens and their generic alternative.
In a strange coincidence, these two high profile glitches in the manufacturing process are occurring at the same time. Fortunately, there is no reason to think this is a sign of things to come. The FDA attributed the EpiPen shortage to manufacturing problems. Meanwhile, a fire at a supplier’s facility caused Ford to run out of parts for the nation’s best-selling vehicle.
Hopefully the two events will serve as an important reminder to Americans of just how delicate a manufacturing supply chain is.